Know Cancer

or
forgot password

Objective Evaluation of Collagen Deposition in AlloMaxTM Acellular Dermal Matrix in Breast Reconstruction Version 8-15-12


N/A
18 Years
70 Years
Not Enrolling
Both
Breast Cancer

Thank you

Trial Information

Objective Evaluation of Collagen Deposition in AlloMaxTM Acellular Dermal Matrix in Breast Reconstruction Version 8-15-12


Inclusion Criteria:



- Adult patients (18 - 70 yrs) who require reconstructive breast surgery with AlloMaxTM
implants and agree to participate will be included in this study.

Exclusion Criteria:

- Patients who do not agree to be included in the study.

Type of Study:

Observational

Study Design:

Observational Model: Case-Only, Time Perspective: Cross-Sectional

Outcome Measure:

Hydroxyproline Concentration

Outcome Description:

Hydroxyproline will be measured in the AlloMaxTM and adjacent capsule.

Outcome Time Frame:

3-4 months

Safety Issue:

No

Principal Investigator

Kayvan Taghipour-Khiabani, M.D.

Investigator Role:

Principal Investigator

Investigator Affiliation:

University of Nevada School of Medicine

Authority:

United States: Institutional Review Board

Study ID:

081512

NCT ID:

NCT01679223

Start Date:

February 2013

Completion Date:

January 2015

Related Keywords:

  • Breast Cancer
  • Breast reconstruction
  • Hydroxyproline concentration
  • neoangiogenesis
  • collagen deposition
  • Breast Neoplasms

Name

Location

University of Nevada School of MedicineReno, Nevada  89503